[

QbDVision for Preclinical

]

Move faster to first-in-human

Structure and connect your development knowledge in a platform that enables you to move faster to IND submission.

Set up scalable, compliant workflows from day one

Establish clear product requirements

Create a product quality profile to ensure product efficacy and patient safety.

Accelerate IND preparation

Organize your CMC data to accelerate IND preparation and minimize risks of IND clinical hold due to CMC deficiencies.

Establish sound data governance

Establish sound data governance and integrity practices early in development.

[

Overview

]

Integrate quality from the start

QbDVision enables preclinical teams to integrate quality into their products and processes from the start. Structuring and contextualizing CMC data streamlines collaboration, accelerates regulatory submission, and creates a trusted foundation for AI, allowing you to move faster to first-in-human with confidence.

[

Process and product feasibility

]

Establish your product and process concept

Define your initial process intent and structure.

Capture assumptions, decisions, and rationale as development evolves.

Explore feasible operating ranges and early hypotheses.

Utilize your structured data to create a coherent story of development intent without locking into final formats.

[

Early risk identification and prioritization

]

Identify and prioritize quality and process risks

Identify, score, and prioritize CQAs, CPPs, and failure modes.

Link risk to mitigation strategies and experiments.

Keep early risk rationale available downstream.

[

Development knowledge capture and reuse

]

Structure R&D knowledge that can be reused later

Create a centralized development knowledge repository that can be reused for future projects.

Maintain traceability across experiments, decisions, and outcomes.

View full version history to see how knowledge evolved throughout a project.

Generate reports that contain development history and rationale.

Real-world impact for CMC teams

[
Top 50 CDMO
]

45%

reduction in time to perform and author risk assessment documents

[
Top 20 pharma
]

60%

reduction in time to perform process risk assessments and generate an FMEA report

[
Top 50 pharma
]

30%

reduction in time to perform historical trend analysis

[

Beyond Implementation

]

Our people-first approach

We partner with pharma, biotech, and CDMO teams to build a platform that captures structured CMC data, preserves process knowledge, and maintains continuity across the full development lifecycle.

We’re here to help you deliver

Explore the world of Digital CMC

[
Blog Post
 I
June 8, 2026
]

Building Scalable AI for CMC

Artificial Intelligence
[
Blog Post
 I
January 26, 2026
]

JPM26 takeaways: The race to AI meets the reality of CMC data maturity

Digital CMC
[
Blog Post
 I
December 12, 2025
]

How Viralgen cut CDMO onboarding from 6-12 months to 3 with Digital CMC

Tech Transfer